Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT00735358
Eligibility Criteria:
Inclusion Criteria:
* Patients with liver cirrhosis and/or hepatoma
* Aged 18 to 80, who had endoscopy-proven acute GVB
* Clinical signs of hematemesis, coffee ground vomitus, hematochezia, or melena
* Endoscopic signs of active bleeding from the GV
* Adherent blood clots, white nipple signs, or erosions on the GV
* The presence of distinct large GV with red-color signs and absence of EV and other bleeding sources
* Who or their legally authorized representatives gave informed consent
Exclusion Criteria:
* Patients had previous endoscopic, surgical treatment or transjugular intrahepatic portosystemic shunt (TIPS) for GVB
* Had a terminal illness of any major organ system, such as heart failure, uremia, chronic pulmonary disease, or non-hepatic malignancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00735358
Study Brief:
Protocol Section:
NCT00735358